No Data
No Data
Huaheng Biotechnology (688639.SH) no longer recognizes Liu Yang as a core technical personnel.
Huaheng Biotechnology (688639.SH) announced that Mr. Liu Yang, the company's core technical staff member, will be temporarily relieved of his work responsibilities due to work duty adjustments...
Huaheng Biotech (688639.SH)'s application to issue shares to specific targets was reviewed and approved by the Shanghai Stock Exchange
Huaheng Biotech (688639.SH) issued an announcement. The company received information from the Shanghai Stock Exchange regarding the company's 2022...
Huaheng Biotech (688639.SH): Ma'anshan Cornerstone plans to reduce its holdings by no more than 2%
Gelonghui, May 24 | Huaheng Biotech (688639.SH) announced that due to its own business needs, Maanshan Cornerstone plans to reduce its total holdings by no more than 2.00% of the company's total shares (i.e. 3,150,803 shares) through centralized bidding and/or bulk transactions. The share reduction plan will be carried out within 6 months after 3 trading days from the date of disclosure of the announcement.
Express News | Huatai Securities: Amino acids replace soybean meal to help food security
Is Anhui Huaheng Biotechnology Co., Ltd.'s (SHSE:688639) Latest Stock Performance Being Led By Its Strong Fundamentals?
Most readers would already know that Anhui Huaheng Biotechnology's (SHSE:688639) stock increased by 4.4% over the past month. Given its impressive performance, we decided to study the company's key
Huaheng Biotech (688639): Performance increased year-on-year, new products are being released soon
The incident described that in 2023, the company achieved revenue of 1.94 billion yuan (+36.6% year over year), achieved vested net profit of 450 million yuan (+40.3% year over year), and realized 440 million yuan in attributable deducted non-net profit (+44 year over year).
No Data